Patent 6946115 was granted and assigned to METABASIS THERAPEUTICS, INC. on September, 2005 by the United States Patent and Trademark Office.
Prodrugs of formula I, their uses, their intermediates, and their method of manufacturing are described:and pharmaceutically acceptable prodrugs and salts thereof.